A$0.08 0.0 2.6%
Last Trade - 26/02/21
| Market Cap | ÂŁ46.5m |
| Enterprise Value | ÂŁ43.1m |
| Revenue | ÂŁ167k |
| Position in Universe | 900th / 1832 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.001 | 0.001 | 0.031 | 0.051 | 0.22 | 0.30 | 3.30 | 5.60 | +252% | ||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
PainChek Ltd, formerly EPAT Technologies Limited, is an Australia-based company, which is principally engaged in developing mobile medical application that provide pain assessment for individuals that are unable to communicate with their carers. The Company's mobile medical application, Painchek, uses the facial recognition software to facilitate and improve pain assessment in patients. The Company intends to develop, and has rolled out its mobile medical applications in two phases, which include patients with dementia and lost the ability to communicate with their carers and for young children not yet speaking. The data captured through the mobile medical applications is combined with non-facial pain cues, including vocalizations, movements and behaviors to automatically calculate a pain severity score.
| Last Annual | June 30th, 2020 |
| Last Interim | June 30th, 2020 |
| Incorporated | August 27, 2010 |
| Public Since | May 1, 2012 |
| No. of Shareholders: | 5,106 |
| No. of Employees: | n/a |
| Sector | Technology |
| Industry | Software & IT Services |
| Index | S&P/ASX All Ordinaries , |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 1,035,522,400 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | SE 401 35 Lime St, SYDNEY, 2000, Australia |
| Web | http://www.painchek.com |
| Phone | +61 8 92004436 |
| Contact | () |
| Auditors | BDO Audit Pty Ltd |
As of 26/02/21, shares in PainChek are trading at A$0.08, giving the company a market capitalisation of ÂŁ46.5m. This share price information is delayed by 15 minutes.
Shares in PainChek are currently trading at A$0.08 and the price has moved by -30.43% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the PainChek price has moved by -32.47% over the past year.
There are no analysts currently covering PainChek.
PainChek is scheduled to issue upcoming financial results on the following dates:
PainChek does not currently pay a dividend.
PainChek does not currently pay a dividend.
PainChek does not currently pay a dividend.
To buy shares in PainChek you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in PainChek are currently trading at A$0.08, giving the company a market capitalisation of ÂŁ46.5m.
Here are the trading details for PainChek:
Based on an overall assessment of its quality, value and momentum, PainChek is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in PainChek are currently priced at A$0.08. At that level they are trading at 0.338% discount to the analyst consensus target price of 0.00.
Analysts covering PainChek currently have a consensus Earnings Per Share (EPS) forecast of -0.003 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PainChek. Over the past six months, the relative strength of its shares against the market has been -28.01%. At the current price of A$0.08, shares in PainChek are trading at -20.87% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for PainChek.
PainChek's management team is headed by:
Here are the top five shareholders of PainChek based on the size of their shareholding:
